Cholera

References

Key articles

Sack DA, Sack RB, Nair GB, et al. Cholera. Lancet. 2004 Jan 17;363(9404):223-33. Abstract

Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet. 2012 Jun 3;379(9835):2466-76. Abstract

Das JK, Tripathi A, Ali A, et al. Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus. BMC Public Health. 2013 Sep 17;13(suppl 3):S11.Full text  Abstract

Bhattacharya SK, Sur D, Ali M, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013 Dec;13(12):1050-6. Abstract

Ali M, Sur D, You YA, et al. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis. 2013 Apr;56(8):1123-31.Full text  Abstract

Leibovici-Weissman Y, Neuberger A, Bitterman R, et al. Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev. 2014 Jun 19;(6):CD008625.Full text  Abstract

Nelson EJ, Nelson DS, Salam MA, et al. Antibiotics for both moderate and severe cholera. N Engl J Med. 2011 Jan 6;364(1):5-7.Full text  Abstract

Reference articles

1. Sack DA, Sack RB, Nair GB, et al. Cholera. Lancet. 2004 Jan 17;363(9404):223-33. Abstract

2. Siddique AK, Nair GB, Alam M, et al. El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect. 2010 Mar;138(3):347-52. Abstract

3. World Health Organization. Fact sheet on cholera. Jan 2019 [internet publication].Full text

4. Diop SA, Manga NM, Dia NM, et al. Cholera and pregnancy: epidemiological, clinical, and evolutionary aspects [in French]. Med Mal Infect. 2007 Dec;37(12):816-20. Abstract

5. Tran NT, Taylor R, Antierens A, et al. Cholera in pregnancy: a systematic review and meta-analysis of fetal, neonatal, and maternal mortality. 2015 Jul 15;10(7):e0132920.Full text  Abstract

6. World Health Organization. Cholera, 2015. Wkly Epidemiol Rec. 2016 Sep 23;91(38):433-40.Full text  Abstract

7. Ali M, Lopez AL, You YA, et al. The global burden of cholera. Bull World Health Organ. 2012 Mar 1;90(3):209-18A.Full text  Abstract

8. Ali M, Nelson AR, Lopez AL, et al. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003832. Abstract

9. Emch M, Feldacker C, Islam MS, et al. Seasonality of cholera from 1974 to 2005: a review of global patterns. Int J Health Geogr. 2008 Jun 1;7:31.Full text  Abstract

10. World Health Organization. Statement from UNICEF Executive Director Anthony Lake and WHO Director-General Margaret Chan on the cholera outbreak in Yemen as suspected cases exceed 200,000. Jun 2017 [internet publication].Full text

11. Griffith DC, Kelly-Hope LA, Miller MA. Review of reported cholera outbreaks worldwide, 1995-2005. Am J Trop Med Hyg. 2006 Nov;75(5):973-7.Full text  Abstract

12. Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis. 2007 Aug;7(8):521-30. Abstract

13. World Health Organization. Ending cholera: a global roadmap to 2030. Oct 2017 [internet publication].Full text

14. World Health Organization. Cholera, 2018. Wkly Epidemiol Rec. 2019 Nov 29;94(48):561-80.Full text

15. World Health Organization. Cholera, 2007. Wkly Epidemiol Rec. 2008 Aug 1;83(31):269-83.Full text  Abstract

16. Mahalanabis D, Faruque AS, Albert MJ, et al. An epidemic of cholera due to Vibrio cholerae O139 in Dhaka, Bangladesh: clinical and epidemiological features. Epidemiol Infect. 1994 Jun;112(3):463-71. Abstract

17. Morris JG Jr. Cholera and other types of vibriosis: a story of human pandemics and oysters on the half shell. Clin Infect Dis. 2003 Jul 15;37(2):272-80.Full text  Abstract

18. Li M, Shimada T, Morris JG Jr, et al. Evidence for the emergence of non-O1 and non-O139 Vibrio cholerae strains with pathogenic potential by exchange of O-antigen biosynthesis regions. Infect Immun. 2002 May;70(5):2441-53.Full text  Abstract

19. Engel MF, Muijsken MA, Mooi-Kokenberg E, et al. Vibrio cholerae non-O1 bacteraemia: description of three cases in the Netherlands and a literature review. Euro Surveill. 2016 Apr 14;21(15).Full text  Abstract

20. Holbourn KP, Shone CC, Acharya KR. A family of killer toxins: exploring the mechanism of ADP-ribosylating toxins. FEBS J. 2006 Oct;273(20):4579-93.Full text  Abstract

21. Paneth N. Assessing the contributions of John Snow to epidemiology: 150 years after removal of the broad street pump handle. Epidemiology. 2004 Sep;15(5):514-6. Abstract

22. Ries AA, Vugia DJ, Beingolea L, et al. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992 Dec;166(6):1429-33. Abstract

23. Motarjemi Y, Käferstein F, Moy G, et al. Contaminated weaning food: a major risk factor for diarrhoea and associated malnutrition. Bull World Health Organ. 1993;71(1):79-92.Full text  Abstract

24. Gundry S, Wright J, Conroy R. A systematic review of the health outcomes related to household water quality in developing countries. J Water Health. 2004 Mar;2(1):1-13. Abstract

25. Wright J, Gundry S, Conroy R. Household drinking water in developing countries: a systematic review of microbiological contamination between source and point-of-use. Trop Med Int Health. 2004 Jan;9(1):106-17.Full text  Abstract

26. Rabbani GH, Greenough WB 3rd. Food as a vehicle of transmission of cholera. J Diarrhoeal Dis Res. 1999 Mar;17(1):1-9. Abstract

27. Albert MJ. Epidemiology and molecular biology of Vibrio cholerae O139 Bengal. Indian J Med Res. 1996 Jul;104:14-27. Abstract

28. Hashizume M, Wagatsuma Y, Faruque AS, et al. Factors determining vulnerability to diarrhoea during and after severe floods in Bangladesh. J Water Health. 2008 Sep;6(3):323-32. Abstract

29. Evans CA, Gilman RH, Rabbani GH, et al. Gastric acid secretion and enteric infection in Bangladesh. Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):681-5. Abstract

30. Nalin DR, Levine RJ, Levine MM, et al. Cholera, non-vibrio cholera, and stomach acid. Lancet. 1978 Oct 21;2(8095):856-9. Abstract

31. Richterman A, Sainvilien DR, Eberly L, et al. Individual and household risk factors for symptomatic cholera infection: a systematic review and meta-analysis. J Infect Dis. 2018 Oct 15;218(suppl 3):S154-64.Full text  Abstract

32. Berger SA, Young NA, Edberg SC. Relationship between infectious diseases and human blood type. Eur J Clin Microbiol Infect Dis. 1989 Aug;8(8):681-9. Abstract

33. Cohen MB, Giannella RA, Losonsky GA, et al. Validation and characterization of a human volunteer challenge model for cholera by using frozen bacteria of the new Vibrio cholerae epidemic serotype, O139. Infect Immun. 1999 Dec;67(12):6346-9.Full text  Abstract

34. Harris JB, Khan AI, LaRocque RC, et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun. 2005 Nov;73(11):7422-7.Full text  Abstract

35. Palmer DL, Koster FT, Alam AK, et al. Nutritional status: a determinant of severity of diarrhea in patients with cholera. J Infect Dis. 1976 Jul;134(1):8-14. Abstract

36. von Seidlein L, Wang XY, Macuamule A, et al. Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique. Trop Med Int Health. 2008 May;3(5):683-8.Full text  Abstract

37. Colombara DV, Cowgill KD, Faruque AS. Risk factors for severe cholera among children under five in rural and urban Bangladesh, 2000-2008: a hospital-based surveillance study. PLoS One. 2013;8(1):e54395.Full text  Abstract

38. Sinclair D, Abba K, Zaman K, et al. Oral vaccines for preventing cholera. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD008603.Full text  Abstract

39. Saha A, Chowdhury MI, Khanam F, et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age. Vaccine. 2011 Oct 26;29(46):8285-92. Abstract

40. Sur D, Kanungo S, Sah B, et al. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis. 2011 Oct;5(10):e1289.Full text  Abstract

41. Phares CR, Date K, Travers P, et al. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand. Vaccine. 2016 Jan 2;34(1):128-33.Full text  Abstract

42. Qadri F, Ali M, Chowdhury F, et al. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial. Lancet. 2015 Oct 3;386(10001):1362-71. Abstract

43. Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet. 2012 Jun 3;379(9835):2466-76. Abstract

44. Clemens JD, Nair GB, Ahmed T, et al. Cholera. Lancet. 2017 Sep 23;390(10101):1539-49. Abstract

45. Bi Q, Ferreras E, Pezzoli L, et al. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2017 Oct;17(10):1080-8.Full text  Abstract

46. Lopez AL, Deen J, Azman AS, et al. Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and metaanalysis. Clin Infect Dis. 2018 Jun 1;66(12):1960-71.Full text  Abstract

47. Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: use in clinical practice. Lancet Infect Dis. 2006 Jun;6(6):361-73. Abstract

48. Sur D, Lopez AL, Kanungo S, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009 Nov 14;374(9702):1694-702. Abstract

49. Masuet Aumatell C, Ramon Torrell JM, Zuckerman JN. Review of oral cholera vaccines: efficacy in young children. Infect Drug Resist. 2011 Sep 14;4:155-60.Full text  Abstract

50. Das JK, Tripathi A, Ali A, et al. Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus. BMC Public Health. 2013 Sep 17;13(suppl 3):S11.Full text  Abstract

51. Bhattacharya SK, Sur D, Ali M, et al. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2013 Dec;13(12):1050-6. Abstract

52. International Medical Corps (IMC) & International Rescue Committee (IRC). Guidance note on the use of oral cholera vaccines. Mar 2016 [internet publication].Full text

53. World Health Organization. Cholera vaccines: WHO position paper - Recommendations. Vaccine. 2010 Jul 5;28(30):4687-8. Abstract

54. Martin S, Lopez AL, Bellos A, et al. Post-licensure deployment of oral cholera vaccines: a systematic review. Bull World Health Organ. 2014 Dec 1;92(12):881-93.Full text  Abstract

55. Ali M, Sur D, You YA, et al. Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis. 2013 Apr;56(8):1123-31.Full text  Abstract

56. Centers for Disease Control and Prevention. Clinical update: cholera vaccine for travelers. Mar 2020 [internet publication].Full text

57. Libman M, CATMAT. Summary of the Committee to Advise on Tropical Medicine and Travel (CATMAT) statement on travellers' diarrhea. Can Commun Dis Rep. 2015 Nov 5;41(11):272-84.Full text  Abstract

58. Wong KK, Burdette E, Mahon BE, et al. Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine. MMWR Morb Mortal Wkly Rep. 2017 May 12;66(18):482-5. Abstract

59. Chen WH, Cohen MB, Kirkpatrick BD, et al. Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor. Clin Infect Dis. 2016 Jun 1;62(11):1329-35.Full text  Abstract

60. Cabrera A, Lepage JE, Sullivan KM, et al. Vaxchora: a single-dose oral cholera vaccine. Ann Pharmacother. 2017 Jul;51(7):584-9. Abstract

61. Graves PM, Deeks JJ, Demicheli V, et al. Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected). Cochrane Database Syst Rev. 2010 Aug 4;(8):CD000974.Full text  Abstract

62. Vugia DJ, Rodriguez M, Vargas R, et al. Epidemic cholera in Trujillo, Peru 1992: utility of a clinical case definition and shift in Vibrio cholerae O1 serotype. Am J Trop Med Hyg. 1994 May;50(5):566-9. Abstract

63. Swerdlow DL, Ries AA. Cholera in the Americas. Guidelines for the clinician. JAMA. 1992 Mar 18;267(11):1495-9. Abstract

64. Sack DA, Tacket CO, Cohen MB, et al. Validation of a volunteer model of cholera with frozen bacteria as the challenge. Infect Immun. 1998 May;66(5):1968-72.Full text  Abstract

65. Kaushik JS, Gupta P, Faridi MM, et al. Single dose azithromycin versus ciprofloxacin for cholera in children: a randomized controlled trial. Indian Pediatr. 2010 Apr;47(4):309-15. Abstract

66. Chatterjee A, Mahalanabis D, Jalan KN, et al. Plasma specific gravity and haematocrit values as indices of the degree of dehydration in infantile diarrhoea. Indian J Med Res. 1979 Aug;70:229-32. Abstract

67. Cook GC. Gastroenterological emergencies in the tropics. Baillieres Clin Gastroenterol. 1991 Dec;5(4):861-86. Abstract

68. Wang F, Butler T, Rabbani GH, et al. The acidosis of cholera. Contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N Engl J Med. 1986 Dec 18;315(25):1591-5. Abstract

69. Centers for Disease Control and Prevention. Laboratory testing for cholera. Jul 2018 [internet publication].Full text

70. Mandell, GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. New York, NY: Elsevier/Churchill Livingstone; 2005.

71. Nato F, Boutonnier A, Rajerison M, et al. One-step immunochromatographic dipstick tests for rapid detection of Vibrio cholerae O1 and O139 in stool samples. Clin Vaccine Immunol. 2003 May;10(3):476-8.Full text  Abstract

72. Ramamurthy T, Pal A, Bag PK, et al. Detection of cholera toxin gene in stool specimens by polymerase chain reaction: comparison with bead enzyme-linked immunosorbent assay and culture method for laboratory diagnosis of cholera. J Clin Microbiol. 1993 Nov;31(11):3068-70.Full text  Abstract

73. Mundy LS, Shanholtzer CJ, Willard KE, et al. An evaluation of three commercial fecal transport systems for the recovery of enteric pathogens. Am J Clin Pathol. 1991 Sep;96(3):364-7. Abstract

74. Harris JR, Cavallaro EC, de Nobrega AA, et al. Field evaluation of crystal VC(R) rapid dipstick test for cholera during a cholera outbreak in Guinea-Bissau. Trop Med Int Health. 2009 Sep;114(9):1117-21. Abstract

75. Centers for Disease Control and Prevention. Laboratory methods for the diagnosis of epidemic dysentery and cholera. 1999 [internet publication].Full text

76. Shirai H, Nishibuchi M, Ramamurthy T, et al. Polymerase chain reaction for detection of the cholera enterotoxin operon of Vibrio cholerae. J Clin Microbiol. 1991 Nov;29(11):2517-21. [Erratum in: J Clin Microbiol. 1992 Jun;30(6):1620.]Full text  Abstract

77. Khuntia HK, Pal BB, Chhotray GP. Quadruplex PCR for simultaneous detection of serotype, biotype, toxigenic potential, and central regulating factor of Vibrio cholerae. J Clin Microbiol. 2008 Jul;46(7):2399-401.Full text  Abstract

78. Yamazaki W, Seto K, Taguchi M, et al. Sensitive and rapid detection of cholera toxin-producing Vibrio cholerae using a loop-mediated isothermal amplification. BMC Microbiol. 2008 Jun 12;8:94.Full text  Abstract

79. Ryan U, Paparini A, Oskam C. New technologies for detection of enteric parasites. Trends Parasitol. 2017 Jul;33(7):532-46. Abstract

80. Saha D, Karim MM, Khan WA, et al. Single-dose azithromycin for the treatment of cholera in adults. N Engl J Med. 2006 Jun 8;354(23):2452-62.Full text  Abstract

81. Weil AA, Khan AI, Chowdhury F, et al. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis. 2009 Nov 15;49(10):1473-9.Full text  Abstract

82. Faruque AS, Mahalanabis D, Islam A, et al. Common diarrhea pathogens and the risk of dehydration in young children with acute watery diarrhea: a case-control study. Am J Trop Med Hyg. 1993 Jul;49(1):93-100. Abstract

83. Alam M, Hasan NA, Sultana M, et al. Diagnostic limitations to accurate diagnosis of cholera. J Clin Microbiol. 2010 Nov;48(11):3918-22. Abstract

84. WHO Global Task Force on Cholera Control. Acute diarrhoeal diseases in complex emergencies: critical steps. 2010 [internet publication].Full text

85. Musekiwa A, Volmink J. Oral rehydration salt solution for treating cholera: <= 270 mOsm/L solutions vs >= 310 mOsm/L solutions. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003754.Full text  Abstract

86. Gregorio GV, Gonzales ML, Dans LF, et al. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev. 2016 Dec 13;(12):CD006519.Full text  Abstract

87. Roy SK, Islam A, Ali R, et al. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children. Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):460-2. Abstract

88. Kabir I, Khan WA, Haider R, et al. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children. J Diarrhoeal Dis Res. 1996 Dec;14(4):243-7. Abstract

89. Leibovici-Weissman Y, Neuberger A, Bitterman R, et al. Antimicrobial drugs for treating cholera. Cochrane Database Syst Rev. 2014 Jun 19;(6):CD008625.Full text  Abstract

90. Nelson EJ, Nelson DS, Salam MA, et al. Antibiotics for both moderate and severe cholera. N Engl J Med. 2011 Jan 6;364(1):5-7.Full text  Abstract

91. Centers for Disease Control and Prevention. Recommendations for the use of antibiotics for the treatment of cholera. Jan 2015 [internet publication].Full text

92. Williams PCM, Berkley JA. Guidelines for the management of paediatric cholera infection: a systematic review of the evidence. Paediatr Int Child Health. 2018 Nov;38(suppl 1):S16-31.Full text  Abstract

93. Alam AN, Alam NH, Ahmed T, et al. Randomised double blind trial of single dose doxycycline for treating cholera in adults. BMJ. 1990 Jun 23;300(6740):1619-21.Full text  Abstract

94. Khan WA, Bennish ML, Seas C, et al. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae O1 or O139. Lancet. 1996 Aug 3;348(9023):296-300. Abstract

95. Roy SK, Hossain MJ, Khatun W, et al. Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial. BMJ. 2008 Feb 2;336(7638):266-8.Full text  Abstract

96. Canani RB, Cirillo P, Buccigrossi V, et al. Zinc inhibits cholera toxin-induced, but not Escherichia coli heat-stable enterotoxin-induced, ion secretion in human enterocytes. J Infect Dis. 2005 Apr 1;191(7):1072-7.Full text  Abstract

97. World Health Organization. Vitamin A supplementation in infants and children 6-59 months of age. 2011 [internet publication].Full text

98. Ghana VAST Study Team. Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions, and child mortality. Lancet. 1993 Jul 3;342(8862):7-12. Abstract

99. Bhandari N, Bahl R, Sazawal S, et al. Breast-feeding status alters the effect of vitamin A treatment during acute diarrhea in children. J Nutr. 1997 Jan;127(1):59-63.Full text  Abstract

100. Imdad A, Mayo-Wilson E, Herzer K, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2017 Mar 11;(3):CD008524.Full text  Abstract

101. Utsalo SJ, Eko FO, Umoh F, et al. Faecal excretion of Vibrio cholerae during convalescence of cholera patients in Calabar, Nigeria. Eur J Epidemiol. 1999 Apr;15(4):379-81. Abstract

102. Echevarría J, Seas C, Carrillo C, et al. Efficacy and tolerability of ciprofloxacin prophylaxis in adult household contacts of patients with cholera. Clin Infect Dis. 1995 Jun;20(6):1480-4. Abstract

103. Reveiz L, Chapman E, Ramon-Pardo P, et al. Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis. PLoS One. 2011 Nov 15;6(11):e27060.Full text  Abstract

Use of this content is subject to our disclaimer